Trulieve · 1 week ago
Director of Investor Relations
Trulieve is seeking a dynamic and strategic Director of Investor Relations and Communications to lead the development and execution of their investor relations strategy and corporate communications. This role is critical in shaping the company’s narrative, fostering strong relationships with the investment community, and ensuring transparent, consistent messaging across all stakeholders.
Responsibilities
Develop and execute a comprehensive investor relations strategy aligned with corporate goals
Serve as a primary point of contact for investors and analysts
Prepare quarterly earnings materials, including scripts, presentations, and Q&A documents
Lead the planning and execution of investor events, including earnings calls, investor days, and roadshows
Monitor analyst reports, market trends, and shareholder sentiment to inform executive leadership
Collaborate with finance, legal, and executive teams to ensure accurate and timely disclosure
Oversee external communications strategy, including press releases, media relations, and crisis communications
Partner with marketing and PR teams to ensure consistent brand messaging across channels
Advise senior leadership on investor perceptions and market dynamics
Develop messaging for M&A, capital raises, and other strategic transactions
Ensure compliance with Canadian and US regulations and disclosure requirements
Qualification
Required
Bachelor's degree in Finance, Communications, Business, or related field; MBA or CFA preferred
8+ years of experience in investor relations, corporate communications, investment banking, or equity research
Strong understanding of financial statements, valuation, and capital markets
Exceptional written and verbal communication skills
Proven ability to build relationships with investors, analysts, and media
Experience in a publicly traded company, preferably in a high-growth or regulated industry
Preferred
Strategic thinker with a proactive, hands-on approach
Comfortable working in a fast-paced, high-visibility environment
Skilled in using IR tools and platforms (Nasdaq IR Insight)
Benefits
Relocation assistance is provided.
Company
Trulieve
Trulieve is a pharmaceutical company that manufactures integrated seed-to-sale medical cannabis products for brain and health treatments.
Funding
Current Stage
Public CompanyTotal Funding
$1.07B2025-12-08Post Ipo Debt· $140M
2023-12-27Post Ipo Debt· $25M
2022-12-21Post Ipo Debt· $71.5M
Leadership Team
Recent News
New Cannabis Ventures
2026-01-09
Company data provided by crunchbase